THERAPEUTISCHE NUKLEOSIDE

Patent europeic · EP0628044 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0628044
Numer da la dumonda
EP93904248
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
24-02-1993
Publitgà
14-12-1994
Concedì
23-07-2003
Stritgà
23-02-2013
Motiv
Durada maximala cuntanschida
Classas IPC
C07D 473/00 (2006.01)
C07C 217/52 (2006.01)
C07D 221/22 (2006.01)
A61K 31/52 (2006.01)
Prioritad
GB 9204015 25.02.1992
Dumonda PCT
PCT/GB1993/000378 24.02.1993
Publicaziun PCT
WO1993/017020 02.09.1993
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 25-02-2013

    Durada maximala cuntanschida

    Published in Swissreg on 25.02.2013

  2. 28-09-2007

    Adressa midada

    Representative
    Isler & Pedrazzini AG, Gotthardstrasse 53, 8023 Zürich → Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich

    Published in +pat+ No 18 in 2007

  3. 15-10-2003

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Gotthardstrasse 53, 8023 Zürich

    Published in +pat+ No 19 in 2003

  4. 31-07-2003

    Concedì

    Published in +pat+ No 14 in 2003

Partidas

Inventur

DALUGE, Susan, Mary

Chapel Hill, NC 27514, US

LIVINGSTON, Douglas Alan

San Diego, CA 92121, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.